It has been another dramatic week on the global markets, with the Pound Sterling falling to a 2022-low and the
YESTERDAY morning the Home Affairs Committee held the opening session of its new inquiry into drugs, seeking to examine the
OXFORD Cannabinoid Technologies Holdings plc (LSE: OCTP, OTCQB: OCTHF), the pharmaceutical company developing prescription cannabinoid medicines targeting the US$ multi-billion
FOOTPRINT Hexo closing Belleville facility Approximately 230 employees will be impacted by Quebec-based Hexo’s latest announcement that it is closing
The company provides compliant banking and financial services to the growing US cannabis industry.
Bill Purves has joined Brains Bioceutical as chief commercial officer.
Oxford Cannabinoid Technologies’ (OCT) shareholders have voted to keep all eight of its current directors, following calls from its co-founder to oust them.
LAST week saw the highly anticipated publication of the Food Standards Agency’s (FSA) Public List, including 3536 CBD products which
The development has been described as both a “milestone” and a “monumental waste of time and money”.
DESPITE being one of the key policies of the ‘Traffic-Light’ German Government do not expect cannabis legalisation to be enacted
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.